Evidence map›Paper›PMID 31334299›Full record

ReviewOpen forum infectious diseases2019

Stephanie LaVergne, Thaidra Gaufin, Douglas Richman

Abstract readReview
In one paragraph

Review in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. IDCases · 2026
    Article
  2. Article
  3. Article
  4. A New Emerging Threat in Critical Care:Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  5. Article
  6. Journal of community hospital internal medicine perspectives · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. IntracranialInfection and drug resistance · 2023
    Article
  11. Article
  12. Extensively Drug-ResistantCase reports in infectious diseases · 2022
    Article
  13. Multiomics Study RevealsFrontiers in microbiology · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. IDCases · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stephanie LaVergneDivision of Infectious Diseases, University of California, San Diego, La Jolla, California.
Thaidra GaufinDivision of Infectious Diseases, University of California, San Diego, La Jolla, California.
Douglas RichmanVA San Diego Healthcare System and Division of Infectious Diseases, University of California, San Diego, La Jolla, California.

Funding

RESEARCH IN INFECTIOUS DISEASEST32AI007036 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NIZET, VICTOR · 1985 to 2025
$9.2M
NIAID NIH HHS T32 AI007036
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cellulitismultidrug resistanceMyroides

Identifiers

PMID31334299
PMCPMC6634436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.